Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-86.70M
↑ 35% above average
Average (9y)
$-132.74M
Historical baseline
Range
High:$734.30M
Low:$-461.82M
CAGR
+12.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-86.70M | +64.3% |
| 2023 | $-243.11M | +24.9% |
| 2022 | $-323.87M | +29.9% |
| 2021 | $-461.82M | -17.1% |
| 2020 | $-394.33M | -3.0% |
| 2019 | $-382.70M | -152.1% |
| 2018 | $734.30M | +1826.9% |
| 2017 | $-42.52M | +56.3% |
| 2016 | $-97.27M | -231.2% |
| 2015 | $-29.37M | - |